United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for BetterLife Pharma Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
| ROE | -43.61% | -54.32% | -118.7% | 634.62% | 86.42% | 46.42% |
|---|---|---|---|---|---|---|
| Sector average | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% | -56.18% |
| ROA | -21.12% | -21.3% | -21.93% | -21.93% | -21.94% | -21.98% |
| Total Assets | $7,079.88K | $6,672.98K | $6,672.98K | $6,672.98K | $6,672.98K | $6,672.98K |
| Net Income | -$1,495.49K | -$1,464.72K | -$1,463.13K | -$1,463.35K | -$1,464.28K | -$1,466.83K |